Wikipedia:Version 1.0 Editorial Team/Hematology-oncology articles by quality log
 | This is a log of operations by a bot. The contents of this page are unlikely to need human editing. In particular, links should not be disambiguated as this is a historical record. |
November 30, 2024
[edit]Reassessed
[edit]- Elizabeth M. Ward (talk) reassessed. Quality rating changed from Start-Class to C-Class. (rev · t)
November 29, 2024
[edit]Reassessed
[edit]- Nodular sclerosing Hodgkin lymphoma (talk) reassessed. Quality rating changed from NA-Class to Stub-Class. (rev · t) Importance rating changed from NA-Class to Unknown-Class. (rev · t)
November 24, 2024
[edit]Reassessed
[edit]- Consensus Development Program (talk) reassessed. Quality rating changed from Start-Class to Stub-Class. (rev · t)
- Robert Bell (physician) (talk) reassessed. Quality rating changed from Start-Class to C-Class. (rev · t)
- Sabizabulin (talk) reassessed. Quality rating changed from Stub-Class to Start-Class. (rev · t)